THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE

Develops and implements precision medicine approaches for pets, particularly in oncology, through initiatives like Vidium, which focuses on advancing cancer treatments for dogs.

Develops and implements precision medicine approaches for pets, particularly in oncology, through initiatives like Vidium, which focuses on advancing cancer treatments for dogs.

Advances veterinary oncology through precision medicine programs, including the Vidium initiative and research on canine cancer and SARS-CoV-2 infection in dogs.

Advances cancer treatments for dogs through the Vidium initiative and develops precision medicine approaches in veterinary oncology, including research on SARS-CoV-2 infection in dogs.

Advances cancer treatments for dogs through Vidium, a precision medicine initiative, and develops targeted oncology therapies for pets using genomic and translational research approaches.

Conducts research on infectious diseases, including studies on the West Nile virus and SARS-CoV-2 infection in dogs.

Conducts research on infectious diseases, including studies on the West Nile virus and SARS-CoV-2 infection in dogs.

Upgrades equipment and software at the Collaborative Sequencing Center to enhance the efficiency, accuracy, and affordability of next-generation sequencing.

Upgrades equipment and software at the Collaborative Sequencing Center to enhance the efficiency, accuracy, and affordability of next-generation sequencing.

Upgrades equipment and software at the Collaborative Sequencing Center to increase the efficiency, accuracy, and affordability of next-generation sequencing, supporting broader research capabilities.

Upgrades equipment and software at the Collaborative Sequencing Center to improve the efficiency, accuracy, and affordability of next-generation sequencing technologies.

Upgrades equipment and software at the Collaborative Sequencing Center to improve the efficiency, accuracy, and affordability of next-generation sequencing.

Organizes and hosts the annual Runway for Research event, a fashion show and fundraiser held at Scottsdale Fashion Square, to support research on women’s cancers.

Organizes annual fundraising events such as the Runway for Research fashion show to support women’s cancer research, including a 2023 event held at Scottsdale Fashion Square.

Organizes an annual fashion show and fundraiser, such as the Runway for Research event, to support women’s cancer research.

Organizes an annual fashion show and fundraiser, such as the Runway for Research event, to support women’s cancer research.

Conducts the MindCrowd study, a large-scale cognitive research project that has engaged nearly 1 million participants as of 2025, aimed at understanding memory and brain health.

Conducts population-scale research studies such as MindCrowd, which has engaged nearly 1 million participants as of 2025, to advance understanding of cognitive health.

Conducts the MindCrowd study, a research initiative that has engaged nearly 1 million participants as of 2025.

Conducts the MindCrowd study, a research initiative that has engaged nearly 1 million participants as of 2025.

Reviews an average of four new research protocols annually related to recombinant or synthetic nucleic acid molecules and maintains public access to approved minutes from Institutional Biosafety Committee meetings.

Reviews an average of four new research protocols annually related to recombinant or synthetic nucleic acid molecules and maintains public access to approved minutes from Institutional Biosafety Committee meetings.

Reviews an average of 4 new research protocols annually involving recombinant or synthetic nucleic acid molecules and maintains public access to Institutional Biosafety Committee meeting minutes.

Reviews an average of four new research protocols annually involving recombinant or synthetic nucleic acid molecules, maintains public access to Institutional Biosafety Committee meeting minutes, and enforces a Conflicts of Interest Policy to ensure research integrity.

Utilizes genomic testing to accelerate diagnosis and enhance patient outcomes in the areas of cancer, rare diseases, and infectious threats.

Utilizes genomic testing to accelerate diagnosis and enhance patient outcomes in the areas of cancer, rare diseases, and infectious threats.

Publishes studies investigating the mechanism linking obesity to increased cancer risk across multiple organs, detailing the impact of BMI on organ growth and cell hyperplasia.

Publishes studies investigating the mechanism linking obesity to increased cancer risk across multiple organs, detailing the impact of BMI on organ growth and cell hyperplasia.

Establishes and maintains a Conflicts of Interest Policy to identify and manage potential conflicts within its research activities.

Establishes and maintains a Conflicts of Interest Policy to identify and manage potential conflicts within its research activities.

Conducts genomic testing and research to accelerate diagnosis and improve patient outcomes in cancer, rare diseases, and infectious diseases such as West Nile virus and SARS-CoV-2. Research includes studying the biological mechanisms linking obesity to increased cancer risk across multiple organs.

Conducts genomic testing and research to accelerate diagnosis and improve patient outcomes in cancer, rare diseases, and infectious diseases such as West Nile virus and SARS-CoV-2. Research includes studies on obesity-related cancer risk and large-scale cognitive research through the MindCrowd study, which has reached nearly 1 million participants as of 2025.

Conducts genomic research to shorten diagnosis times and improve patient outcomes in cancer, rare diseases, and infectious diseases, including studies on West Nile virus, obesity-related cancer risk, and SARS-CoV-2 infection.

Implements a Conflicts of Interest Policy to identify and manage potential conflicts in research activities.